Description
The BioSMB Process system uses the principle of multi-column chromatography to enable manufacturers to fully utilize resins at clinical and commercial scale, significantly reducing resin costs. In fact, the BioSMB platform is the first single-use solution on the market that can be scaled up from process development to commercial manufacturing.